Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI North America CPhI North America
Not Confirmed
Not Confirmed
20-22 May, 2025
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
American Thoracic Soci...American Thoracic Society
Not Confirmed
Not Confirmed
18-21 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
American Thoracic Soci...American Thoracic Society
Industry Trade Show
Not Confirmed
18-21 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
14 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/adc-therapeutics-drops-last-clinical-stage-after-reviewing-phase-1-leukemia-data
14 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adc-therapeutics-announces-presentation-of-lotis-7-clinical-trial-data-at-the-european-hematology-association-2025-congress-eha2025-and-the-18th-international-conference-on-malignant-lymphoma-icml-302454626.html
01 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adc-therapeutics-makes-grants-to-new-employees-under-inducement-plan-302414722.html
30 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adc-therapeutics-announces-completion-of-enrollment-of-phase-3-confirmatory-clinical-trial-of-zynlonta-in-combination-with-rituximab-in-2l-diffuse-large-b-cell-lymphoma-302338974.html
11 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adc-therapeutics-announces-positive-initial-data-from-lotis-7-clinical-trial-evaluating-zynlonta-in-combination-with-bispecific-antibody-in-patients-with-relapsedrefractory-diffuse-large-b-cell-lymphoma-302328090.html
09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/adc-therapeutics-announces-the-lancet-haematology-publication-of-data-from-investigator-initiated-trial-evaluating-zynlonta-in-combination-with-rituximab-to-treat-relapsedrefractory-follicular-lymphoma-302325360.html
ABOUT THIS PAGE
ADC Therapeutics is a supplier offers 4 products (APIs, Excipients or Intermediates).
Find a price of PL1601 DRUG LINKER bulk with DMF offered by ADC Therapeutics
Find a price of ADCT-701 DRUG PRODUCT bulk with DMF offered by ADC Therapeutics
Find a price of HUBA-1-3D-GAINACN3 MAB bulk with DMF offered by ADC Therapeutics
Find a price of ADCT-701 DRUG SUBSTANCE bulk with DMF offered by ADC Therapeutics